High HSPB1 expression predicts poor clinical outcomes and correlates with breast cancer metastasis

BACKGROUND: Heat shock protein beta-1 (HSPB1) is a crucial biomarker for pathological processes in various cancers. However, the clinical value and function of HSPB1 in breast cancer has not been extensively explored. Therefore, we adopted a systematic and comprehensive approach to investigate the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Huo, Qin, Wang, Juan, Xie, Ni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239126/
https://www.ncbi.nlm.nih.gov/pubmed/37268925
http://dx.doi.org/10.1186/s12885-023-10983-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239126/
https://www.ncbi.nlm.nih.gov/pubmed/37268925
http://dx.doi.org/10.1186/s12885-023-10983-3

Ejemplares similares